v3.19.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Income:    
Revenue
Expenses:    
Research and development 85,066 456,360
General and administrative 751,251 936,780
Interest 394,943 320,093
Total expenses 1,231,260 1,713,233
Gain on settlement of accounts payable 184,789
Net loss $ (1,046,471) $ (1,713,233)
Loss per share:    
Basic and diluted (in dollars per share) $ (0.015) $ (0.067)
Weighted average shares outstanding, basic and diluted (in shares) 67,909,853 25,461,630

Source